[HTML][HTML] Five-gene signature associating with Gleason score serve as novel biomarkers for identifying early recurring events and contributing to early diagnosis for …
L Zhang, Y Li, X Wang, Y Ping, D Wang, Y Cao… - Journal of …, 2021 - ncbi.nlm.nih.gov
Background: Compared to non-recurrent type, recurrent prostate adenocarcinoma (PCa) is
highly fatal, and significantly shortens the survival time of affected patients. Early and …
highly fatal, and significantly shortens the survival time of affected patients. Early and …
Five-gene signature associating with Gleason score serve as novel biomarkers for identifying early recurring events and contributing to early diagnosis for Prostate …
L Zhang, Y Li, X Wang, Y Ping, D Wang, Y Cao… - Journal of …, 2021 - europepmc.org
Background: Compared to non-recurrent type, recurrent prostate adenocarcinoma (PCa) is
highly fatal, and significantly shortens the survival time of affected patients. Early and …
highly fatal, and significantly shortens the survival time of affected patients. Early and …
Five-gene signature associating with Gleason score serve as novel biomarkers for identifying early recurring events and contributing to early diagnosis for Prostate …
L Zhang, Y Li, X Wang, P Ying, D Wang… - Journal of …, 2021 - search.proquest.com
Background: Compared to non-recurrent type, recurrent prostate adenocarcinoma (PCa) is
highly fatal, and significantly shortens the survival time of affected patients. Early and …
highly fatal, and significantly shortens the survival time of affected patients. Early and …
[HTML][HTML] Five-gene signature associating with Gleason score serve as novel biomarkers for identifying early recurring events and contributing to early diagnosis for …
L Zhang, Y Li, X Wang, Y Ping, D Wang, Y Cao… - Journal of …, 2021 - jcancer.org
Background: Compared to non-recurrent type, recurrent prostate adenocarcinoma (PCa) is
highly fatal, and significantly shortens the survival time of affected patients. Early and …
highly fatal, and significantly shortens the survival time of affected patients. Early and …
Five-gene signature associating with Gleason score serve as novel biomarkers for identifying early recurring events and contributing to early diagnosis for Prostate …
L Zhang, Y Li, X Wang, Y Ping, D Wang… - Journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Background: Compared to non-recurrent type, recurrent prostate adenocarcinoma (PCa) is
highly fatal, and significantly shortens the survival time of affected patients. Early and …
highly fatal, and significantly shortens the survival time of affected patients. Early and …
[PDF][PDF] Five-gene signature associating with Gleason score serve as novel biomarkers for identifying early recurring events and contributing to early diagnosis for …
L Zhang, Y Li, X Wang, Y Ping, D Wang, Y Cao… - Journal of …, 2021 - researchgate.net
Background: Compared to non-recurrent type, recurrent prostate adenocarcinoma (PCa) is
highly fatal, and significantly shortens the survival time of affected patients. Early and …
highly fatal, and significantly shortens the survival time of affected patients. Early and …
[PDF][PDF] Five-gene signature associating with Gleason score serve as novel biomarkers for identifying early recurring events and contributing to early diagnosis for …
L Zhang, Y Li, X Wang, Y Ping, D Wang, Y Cao… - Journal of …, 2021 - researchgate.net
Background: Compared to non-recurrent type, recurrent prostate adenocarcinoma (PCa) is
highly fatal, and significantly shortens the survival time of affected patients. Early and …
highly fatal, and significantly shortens the survival time of affected patients. Early and …
Five-gene signature associating with Gleason score serve as novel biomarkers for identifying early recurring events and contributing to early diagnosis for Prostate …
L Zhang, Y Li, X Wang, Y Ping, D Wang, Y Cao… - Journal of …, 2021 - europepmc.org
Background: Compared to non-recurrent type, recurrent prostate adenocarcinoma (PCa) is
highly fatal, and significantly shortens the survival time of affected patients. Early and …
highly fatal, and significantly shortens the survival time of affected patients. Early and …